Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Meredith B Brooks, Ph.D.

Title
Institution
Department
Address
Phone

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. DP2MD015102 (YUEN, COURTNEY MINGMEN) Aug 23, 2019 - May 31, 2024
    NIH/NIMHD
    New approaches to optimizing the application and measuring the impact of community-based tuberculosis interventions
    Role: Co-Investigator
  2. F32AI145095 (BROOKS, MEREDITH BLAIR) Aug 22, 2019
    NIH/NIAID
    Geospatial Signals in Pediatric Tuberculosis Epidemiology
    Role: Principal Investigator
  3. 15020 (Meredith Brooks) Jan 1, 2019 - Dec 31, 2020
    Thrasher Research Fund
    Optimizing diagnostic algorithms for prompt detection of childhood tuberculosis
    Role: Principal Investigator
  4. U01AI091429 (MITNICK, CAROLE D) Aug 20, 2011 - Jul 31, 2014
    NIH/NIAID
    Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chiang SS, Brooks MB, Jenkins HE, Rubenstein D, Seddon JA, van de Water BJ, Lindeborg MM, Becerra MC, Yuen CM. Concordance of drug resistance profiles between persons with drug-resistant tuberculosis and their household contacts: a systematic review and meta-analysis. Clin Infect Dis. 2020 May 25. PMID: 32448887.
    Citations:    
  2. Hamid M, Brooks MB, Madhani F, Ali H, Naseer MJ, Becerra M, Amanullah F. Risk factors for unsuccessful tuberculosis treatment outcomes in children. PLoS One. 2019; 14(9):e0222776. PMID: 31553758.
    Citations:    
  3. Siddiqui S, Brooks MB, Malik AA, Fuad J, Nazish A, Bano S, Becerra MC, Hussain H. Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan. PLoS One. 2019; 14(8):e0221485. PMID: 31425565.
    Citations:    
  4. Velásquez GE, Brooks MB, Coit JM, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Lecca L, Davies GR, Mitnick CD. Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis. Am J Respir Crit Care Med. 2019 05 01; 199(9):1167-1168. PMID: 30645140.
    Citations:    Fields:    
  5. Malik AA, Brooks MB, Siddiqui S, Fuad J, Peloquin CA, Amanullah F, Jaswal M, Becerra MC, Hussain H, Yuen CM. Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2019 05; 63(5). PMID: 30803975.
    Citations:    
  6. Rodriguez CA, Brooks MB, Guglielmetti L, Hewison C, Jachym MF, Lessem E, Varaine F, Mitnick CD. Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods study. Public Health Action. 2019 Mar 21; 9(1):32-41. PMID: 30963040.
    Citations:    
  7. Le H, Nguyen N, Tran P, Hoa N, Hung N, Moran A, Mossawi HJA, Kak N, Ahmedov S, Brooks MB, Nardell EA, Tierney DB. Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment. Int J Tuberc Lung Dis. 2019 02 01; 23(2):140-146. PMID: 30621813.
    Citations:    Fields:    
  8. Yuen C, Nathavitharana R, Brooks M, Vineberg J, Becerra M, Keshavjee S. Synthesis of Guidelines on TB Infection Treatment: A tool for Zero TB coalitions. ZeroTB Initiative. 2019. View Publication.
  9. Brooks MB, Keshavjee S, Gelmanova I, Zemlyanaya NA, Mitnick CD, Manjourides J. Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts. BMC Med Res Methodol. 2018 12 11; 18(1):166. PMID: 30537944.
    Citations:    Fields:    
  10. Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 09 01; 198(5):657-666. PMID: 29954183.
    Citations:    Fields:    
  11. Shen JG, Brooks MB, Cincotta J, Manjourides JD. Establishing a relationship between the effect of caffeine and duration of endurance athletic time trial events: A systematic review and meta-analysis. J Sci Med Sport. 2019 Feb; 22(2):232-238. PMID: 30170953.
    Citations:    Fields:    Translation:Humans
  12. Brooks M, Noyes E, Hussain H, Malik A, Jaswal M, Siddiqui S, Barry Z, Fuad J, Becerra M, Seddon J, Furin J. How to care for people exposed to drug-resistant tuberculosis: a practical guide. The Sentinel Project for Pediatric Drug-Resistant Tuberculosis. 2018. View Publication.
  13. Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito ES, Vasquez DV, Mitnick CD, Davies G. Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis". Antimicrob Agents Chemother. 2017 09; 61(9). PMID: 28839086.
    Citations: 1     Fields:    
  14. Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Sanchez Garavito E, Vargas Vasquez D, Mitnick CD, Davies G. Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis. Antimicrob Agents Chemother. 2017 08; 61(8). PMID: 28559269.
    Citations: 5     Fields:    Translation:HumansCellsCTClinical Trials
  15. Brooks MB. Bias reduction in the presence of informative censoring: application of the Cox model to multidrug-resistant tuberculosis cohort analyses. 2017. View Publication.
  16. Nourzad S, Jenkins HE, Milstein M, Mitnick CD. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis. Int J Tuberc Lung Dis. 2017 01 01; 21(1):6-11. PMID: 28157458.
    Citations:    Fields:    Translation:Humans
  17. Cellamare M, Milstein M, Ventz S, Baudin E, Trippa L, Mitnick CD. Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial. Int J Tuberc Lung Dis. 2016 12 01; 20(12):8-12. PMID: 28240566.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  18. Milstein M, Brzezinski A, Varaine F, Mitnick CD. (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2016 12 01; 20(12):18-23. PMID: 28240568.
    Citations:    Fields:    Translation:Humans
  19. Tierney DB, Milstein MB, Manjourides J, Furin JJ, Mitnick CD. Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru. Glob Pediatr Health. 2016; 3:2333794X16674382. PMID: 27826599.
    Citations:    
  20. Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, Becerra MC, Burgos M, Centis R, Cohen T, Cox H, D'Ambrosio L, Danilovitz M, Falzon D, Gelmanova IY, Gler MT, Grinsdale JA, Holtz TH, Keshavjee S, Leimane V, Menzies D, Migliori GB, Milstein MB, Mishustin SP, Pagano M, Quelapio MI, Shean K, Shin SS, Tolman AW, van der Walt ML, Van Deun A, Viiklepp P. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. Eur Respir J. 2016 10; 48(4):1160-1170. PMID: 27587552.
    Citations: 2     Fields:    Translation:HumansCells
  21. Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD. Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial. BMC Infect Dis. 2016 08 27; 16(1):453. PMID: 27567500.
    Citations: 4     Fields:    Translation:Humans
  22. Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2014 Oct; 14(10):947-57. PMID: 25108337.
    Citations: 22     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Brooks's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.